Head of Marketing at AstraZeneca

Compensation

$267,913 – $401,870/yr

Setup: Hybrid
Location: Boston, Massachusetts
Type: Full-time
Level: not_specified
Posted: Jul 29, 2026

Description

AstraZeneca is seeking an experienced Global Head of Marketing, Cardio-Renal to accelerate the commercial development of new medicines targeting chronic kidney disease (CKD) and heart failure (HF) prevention. The role involves shaping and implementing brand and therapeutic area strategy, collaborating with cross-functional teams globally, and preparing for outstanding global launches. This position requires deep CVRM expertise, extensive experience in pharmaceutical development and commercialization, and a proven track record of leading cross-functional teams.

Required Skills

Deep CVRM expertise
experience in pharmaceutical development
commercialization
leading and developing cross-functional teams
leveraging clinical data
understanding of forecasting
market research
competitive landscape analysis
leverage AI and digital

Additional Information

Minimum Education: Bachelor's Degree in Business, Medical or Life sciences.
Required Previous Experiences: 15 years’ experience in pharmaceutical development and commercialization
Specialist launch experience in competitive space, preferably on global and/or regional level
Demonstrated success leading and developing cross-functional teams
Experience leveraging clinical data to shape brand strategies and lifecycle planning
Solid understanding of forecasting, market research, useful insight generation, and competitive landscape analysis and interpretation.
Experience from leveraging AI and digital to drive commercial strategy and operational excellence.
Demonstrated ability to collaborate and influence laterally and vertically with senior leadership, cross functional stakeholders and across geographies.
Preferred Qualifications: Advanced degree (MBA, MSc or PhD) in life sciences and/or business management.
US commercial and launch experience.
US and/or global professional relationships with Key External Experts in HF and CKD.

About AstraZeneca

AstraZeneca

biopharmaceutical10001+

AstraZeneca is a global, science-led biopharmaceutical business. Its innovative medicines are used by millions of patients worldwide. The company invests in transformative technologies and commercial execution to bring its medicines to patients around the globe and drive growth beyond 2030. Its pipeline includes 183 projects; the company also reported six key positive Phase III programmes and eight first approvals in major markets in the first half.

View full company profile